- Mobile Health and mHealth Applications
- Medication Adherence and Compliance
- Chronic Myeloid Leukemia Treatments
- Economic and Financial Impacts of Cancer
- Health Literacy and Information Accessibility
- Telemedicine and Telehealth Implementation
- Pharmaceutical studies and practices
- Medical Research and Practices
- Literature Analysis and Criticism
- Cancer survivorship and care
- Neutropenia and Cancer Infections
- Healthcare during COVID-19 Pandemic
- Chronic Disease Management Strategies
- Pharmaceutical Practices and Patient Outcomes
Radboud University Medical Center
2021-2023
Radboud University Nijmegen
2021-2023
Substantial proliferation of eHealth has enabled a move in patient-centred cancer care from the traditional in-person model to real-time, dynamic, and technology supported on-demand care. However, general, uptake these innovations is low. Studies show that helpful providing patient empowerment through e.g. high quality timely information, enabling self-monitoring shared decision making, but dropout rates are guidance for optimal implementation lacking.To explore barriers facilitators...
For patients with chronic myeloid leukemia, a web-based platform CMyLife was developed. Its aim is to enhance patient empowerment, by adequate information provision, among others. Before evaluating its effect, provision and needs in current care were assessed. To assess patients' evaluation of received before utilization whether this source used correspondingly. Additionally, we explored predicting factors perception. developed active participation. We conducted cross-sectional survey 203...
Abstract Background Two most important factors determining treatment success in chronic myeloid leukemia (CML) are adequate medication compliance and molecular monitoring albeit still being suboptimal. The CMyLife platform is an eHealth innovation, co-created with for CML patients, aiming to improve their care, leading increased quality of life the opportunity hospital-free care. Objective To explore effectiveness terms information provision, patient empowerment, compliance, monitoring,...
Background The evaluation of a continuously evolving eHealth tool in terms improvement and implementation daily practice is unclear. CMyLife digital care platform provides patient-centered by empowering patients with chronic myeloid leukemia, focus on making medication compliance insightful, discussable, optimal, achieving optimal control the biomarker BCR-ABL1. Objective aim this study was to investigate what extent participatory action research approach suitable for scientific innovations...
<sec> <title>BACKGROUND</title> The evaluation of a continuously evolving eHealth tool in terms improvement and implementation daily practice is unclear. CMyLife digital care platform provides patient-centered by empowering patients with chronic myeloid leukemia, focus on making medication compliance insightful, discussable, optimal, achieving optimal control the biomarker BCR-ABL1. </sec> <title>OBJECTIVE</title> aim this study was to investigate what extent participatory action research...
<sec> <title>BACKGROUND</title> Oncological health care services are challenged by the increasing number of cancer survivors, long-term follow-up care, and fragmentation care. Digital platforms potential tools to deliver affordable, patient-centered oncological Previous reviews evaluated only one feature a digital platform or did not evaluate effect on enhancement information, self-efficacy, continuity patient- provider–reported experiences. Additionally, they have focused barriers...
<sec> <title>BACKGROUND</title> The two most important factors determining treatment success in chronic myeloid leukemia (CML) are adequate medication compliance and molecular monitoring, but both still suboptimal. CMyLife platform is an eHealth innovation, co-created with for CML patients. aims to provide these patients tools knowledge have more control over their disease process improve monitoring. This could eventually lead increased quality of life the opportunity hospital-free care....